SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-009885
Filing Date
2024-04-02
Accepted
2024-04-02 20:42:06
Documents
1
Period of Report
2024-04-02

Document Format Files

Seq Description Document Type Size
1 form4-04032024_120459.html 4  
1 form4-04032024_120459.xml 4 9668
  Complete submission text file 0001415889-24-009885.txt   11407
Mailing Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121
Business Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Issuer) CIK: 0001782303 (see all company filings)

IRS No.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210
Business Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210 (617) 951-5372
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (Reporting) CIK: 0001787092 (see all company filings)

State of Incorp.: E9
Type: 4 | Act: 34 | File No.: 001-41989 | Film No.: 24816612